Your browser version may not work well with NCBI's Web applications. More information here...
1: South Med J. 2005 Sep;98(9):940-2. Links

Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature.

Korkmaz C, Adapinar B, Uysal S.

Division of Rheumatology, Department of Internal Medicine, Osmangazi University Medical Faculty, Eskişehir, Turkey. ckorkmaz@ogu.edu.tr

Progressive facial hemiatrophy, also known as Parry-Romberg syndrome (PRS), is characterized by slowly progressive atrophy of one side of the face, primarily involving the subcutaneous tissues and fat. Involvement of the central nervous system with impairment of neurologic function occurs infrequently. At present, there is no agreement as to whether PRS is a distinct entity or a clinical variant of linear scleroderma en coup de sabre. The exact reason for PRS has not yet been determined; therefore, no suitable treatment exists. We observed beneficial effects of immunosuppressive agents on neurologic lesions in particular in a patient with PRS who presented with immunoinflammatory findings and neurologic involvement, apart from cutaneous manifestations.

PMID: 16217992 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Methotrexate (Rheumatrex® , Trexall® )

    Methotrexate is used to treat severe psoriasis (a skin disease in which red, scaly patches form on some areas of the body) that cannot be controlled by other treatments. Methotrexate is also used along with rest, physica...

  • Source: AHFS Consumer Medication Information